Jean-Frederic Viret

CIK 1427569 · Chief Financial Officer · last filed 2026-02-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$96.2K

Companies

4

Total Filings

43

Lifetime Open-Market Net

-$2.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SGP Chief Financial Officer $18.44 $0 1 2026-02-09
NGM BIOPHARMACEUTICALS INC (NGM) Delisted Chief Financial Officer 0 $1.54 $0 $0 2 2024-04-08
CHRS Chief Financial Officer 68,697 $1.40 $96.2K -$2.85M 36 2021-02-03
ANESIVA, INC. (ANSV) Delisted VP and Chief Financial Officer 6,541 $0 2 2008-12-05

Recent Filings · Page 3 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-08-21 CHRS Sell (S) −3,000 -$57.1K EDGAR
2019-06-20 CHRS Mixed −3,667 -$103.8K EDGAR
2019-03-22 CHRS Sell (S) −3,000 -$44.8K EDGAR
2019-01-15 CHRS Mixed +10,388 -$77.9K EDGAR
2018-09-25 CHRS Exer (M) +740 $10.0K EDGAR
2018-07-25 CHRS Sell (S) −9,291 -$172.5K EDGAR
2018-02-05 CHRS Grant (A) $0 EDGAR
2017-12-19 CHRS Grant (A) +6,966 $0 EDGAR
2017-08-08 CHRS Grant (A) $0 EDGAR
2017-01-27 CHRS Mixed -$52.6K EDGAR
Showing 2130 of 43
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.